Serpine2-flox Mouse
Common Name
Serpine2-flox
제품 ID
S-CKO-05210
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-20720-Serpine2-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Serpine2-flox Mouse (카탈로그 번호 S-CKO-05210)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Serpine2-flox
품종 계통계통 ID
CKOCMP-20720-Serpine2-B6J-VA
유전자명
제품 ID
S-CKO-05210
유전자 별칭
B230326M24Rik, PAI-1, PI-7, PI7, PN-1, Spi4
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 1
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000027467
NCBI 전사체 ID
NM_009255
타겟 영역
Exon 5
유효 영역 크기
~1.9 kb
유전자 연구 개요
Serpine2, also known as Protease Nexin-1, is a serine proteinase inhibitor. Its target specificity can be influenced by extracellular matrix components. It has variable expression in many organs during development, adult stages, pathological situations or after injury. Genetically modified mice serve as useful in vivo models to study its functions [4].
In cancer research, Serpine2 knockdown has been shown to improve tumor radiosensitivity in lung cancer, as it reduces homologous recombination repair, suppresses cell migration and invasion, and inhibits the accumulation of p-ATM and RAD51 during DNA repair [1]. In liver cancer, SERPINE2 promotes metastasis by inhibiting c-Cbl-mediated EGFR ubiquitination and degradation, and its knockdown enhances the efficacy of sorafenib and lenvatinib [2]. In advanced renal cell carcinoma, SERPINE2 knockdown suppresses cell growth and invasion, while overexpression promotes metastasis, and it can activate the epithelial-mesenchymal transition pathway [3]. In esophageal squamous cell carcinoma, SERPINE2 knockdown inhibits tumor cell invasion and metastasis by inducing epithelial-mesenchymal transition through downregulating BMP4 [5]. In urothelial carcinoma, high SERPINE2 expression is associated with adverse pathologic features and poor prognosis [6]. In hepatoblastoma, SERPINE2 overexpression promotes cell migration, invasion, and suppresses apoptosis, and its upregulation is related to poor prognosis [10]. In oral squamous cell carcinoma, SERPINE2 promotes angiogenesis and lymphangiogenesis, and is an independent poor prognostic factor [9]. In human papillary thyroid carcinoma, SERPINE2 forms a positive feedback with EGF/EGFR to regulate cell proliferation, invasion and migration [8].
In conclusion, Serpine2 plays significant roles in multiple biological processes, especially in cancer-related functions such as tumor metastasis, radioresistance, and cell-cycle-related DNA repair. The use of gene knockout or knockdown models in various cancer types has provided crucial insights into Serpine2's functions, suggesting it could be a potential therapeutic target in these diseases. Additionally, in inner ear research, overexpression of Serpine2 promotes hair cell regeneration, indicating its role in tissue repair and regeneration [7].
References:
1. Zhang, Jingjing, Wu, Qiong, Zhu, Lucheng, Ma, Shenglin, Zhang, Shirong. 2021. SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer. In Cancer letters, 524, 268-283. doi:10.1016/j.canlet.2021.10.001. https://pubmed.ncbi.nlm.nih.gov/34648881/
2. Zhang, Shiyu, Jia, Xing, Dai, Haojiang, Zheng, Shusen, Song, Penghong. 2024. SERPINE2 promotes liver cancer metastasis by inhibiting c-Cbl-mediated EGFR ubiquitination and degradation. In Cancer communications (London, England), 44, 384-407. doi:10.1002/cac2.12527. https://pubmed.ncbi.nlm.nih.gov/38407942/
3. Chen, Wen-Jin, Dong, Ke-Qin, Pan, Xiu-Wu, Rini, Brian, Cui, Xin-Gang. 2023. Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma. In Cell death & disease, 14, 30. doi:10.1038/s41419-023-05566-w. https://pubmed.ncbi.nlm.nih.gov/36646679/
4. Monard, Denis. 2016. SERPINE2/Protease Nexin-1 in vivo multiple functions: Does the puzzle make sense? In Seminars in cell & developmental biology, 62, 160-169. doi:10.1016/j.semcdb.2016.08.012. https://pubmed.ncbi.nlm.nih.gov/27545616/
5. Zhang, Jianglan, Luo, Aiping, Huang, Furong, Gong, Tongyang, Liu, Zhihua. 2019. SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4. In Cancer letters, 469, 390-398. doi:10.1016/j.canlet.2019.11.011. https://pubmed.ncbi.nlm.nih.gov/31730904/
6. Chuang, Hao-Wen, Hsia, Kan-Tai, Liao, Jia-Bin, Kuo, Wei-Ting, Yang, Yi-Fang. 2021. SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma. In Diagnostics (Basel, Switzerland), 11, . doi:10.3390/diagnostics11101928. https://pubmed.ncbi.nlm.nih.gov/34679626/
7. Sun, Qiuhan, Tan, Fangzhi, Wang, Xinlin, Qi, Jieyu, Chai, Renjie. 2024. AAV-regulated Serpine2 overexpression promotes hair cell regeneration. In Molecular therapy. Nucleic acids, 35, 102396. doi:10.1016/j.omtn.2024.102396. https://pubmed.ncbi.nlm.nih.gov/39687341/
8. Chu, Huimin, Hu, Bo, Su, Xinyu. 2021. SERPINE2 feedback regulates EGF/EGFR signaling in human papillary thyroid carcinoma cells. In Molecular medicine reports, 23, . doi:10.3892/mmr.2021.11981. https://pubmed.ncbi.nlm.nih.gov/33760135/
9. Sasahira, Tomonori, Kurihara-Shimomura, Miyako, Shimomura, Hiroyuki, Kirita, Tadaaki. 2021. SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis. In International journal of clinical oncology, 26, 1831-1839. doi:10.1007/s10147-021-01970-4. https://pubmed.ncbi.nlm.nih.gov/34173120/
10. Zou, Guoyou, Lv, Yong, Kong, Meng, Xiang, Bo, Chen, Jing. 2022. Upregulation of SERPINE2 Results in Poor Prognosis of Hepatoblastoma via Promoting Invasion Abilities. In Disease markers, 2022, 2283541. doi:10.1155/2022/2283541. https://pubmed.ncbi.nlm.nih.gov/36505099/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
